Answers are grounded in this paper and cite their sources.
Demonstrates ROS-responsive liposomes improve kidney function in acute kidney injury, suggesting a novel intervention strategy.
, inhibited renal cell apoptosis, and reduced the inflammatory response in a renal ischemia-reperfusion injury model. Ultimately, MST achieved superior improvements in renal function, outperforming both non-biomimetic and non-responsive comparators, while demonstrating a favorable preliminary systemic safety profile. This study introduces a promising ROS-responsive biomimetic platform for AKI intervention.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: